Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Aina, Oliver"'
Autor:
Maximilian Merz, Danai Dima, Hamza Hashmi, Nausheen Ahmed, Friedrich Stölzel, Tobias A. W. Holderried, Roland Fenk, Fabian Müller, Natalia Tovar, Aina Oliver-Cáldes, Kristin Rathje, James A. Davis, David Fandrei, Vladan Vucinic, Soraya Kharboutli, Ben-Niklas Baermann, Francis Ayuk, Uwe Platzbecker, Anca-Maria Albici, Nathalie Schub, Friederike Schmitz, Leyla Shune, Jack Khouri, Faiz Anwer, Shahzad Raza, Joseph McGuirk, Zahra Mahmoudjafari, Kimberly Green, Cyrus Khandanpour, Marcel Teichert, Barbara Jeker, Michele Hoffmann, Nicolaus Kröger, Bastian von Tresckow, Carlos Fernández de Larrea, Thomas Pabst, Al-Ola Abdallah, Nico Gagelmann
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Despite the astonishing outcomes after chimeric antigen receptor (CAR) T-cell therapy for relapsed refractory multiple myeloma (RRMM), most patients eventually relapse. There are only limited data available on salvage therapies following rel
Externí odkaz:
https://doaj.org/article/494534289884443fbc7448906d6d0a82
Autor:
Anna deDaniel, Luis Gerardo Rodríguez‐Lobato, Natalia Tovar, M. Teresa Cibeira, David F. Moreno, Aina Oliver‐Caldés, Ignacio Isola, Ester Lozano, Joan Bladé, Laura Rosiñol, Carlos Fernández de Larrea
Publikováno v:
HemaSphere, Vol 8, Iss 5, Pp n/a-n/a (2024)
Abstract The 2/20/20 International Myeloma Working Group (IMWG) score is the most employed risk score in clinical practice to evaluate the risk of progression from smoldering multiple myeloma (SMM) to symptomatic multiple myeloma. However, it faces a
Externí odkaz:
https://doaj.org/article/1de8802a875642aa8d1b51cf74359b01
Autor:
Laura Martinez-Verbo, Lorea Villanueva, Pere Llinàs-Arias, Carlos Antonio García-Prieto, David Piñeyro, Aina Oliver-Caldes, Almudena García-Ortiz, Antonio Valeri, Carlos Fernández De Larrea, Joaquin Martínez-López, Gerardo Ferrer, Manel Esteller
Publikováno v:
HemaSphere, Vol 7, p e404615e (2023)
Externí odkaz:
https://doaj.org/article/3f9042ac575142cda58a8f1f53d37941
Autor:
Javier Nogués-Castell, Silvia Feu-Basilio, Óscar Felguera García, Carlos Fernández de Larrea, Aina Oliver-Caldés, Olga Balagué Ponz, Jessica Matas Fassi
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundPlasma cell leukemia (PCL) is an aggressive and rare form of plasma cell dyscrasia characterized by peripheral blood expression, poor prognosis, and high relapse rates. Extramedullary plasmacytomas are common in this entity and can affect v
Externí odkaz:
https://doaj.org/article/0e0d1ec5a3954870b2f7786d167338cc
Autor:
Raquel Jiménez-Segura, Laura Rosiñol, Ma Teresa Cibeira, Carlos Fernández de Larrea, Natalia Tovar, Luis Gerardo Rodríguez-Lobato, Esther Bladé, David F. Moreno, Aina Oliver-Caldés, Joan Bladé
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 9, Pp 1-8 (2022)
Abstract From January 1970 to December 2018, 1304 patients were diagnosed with multiple myeloma (MM) at our institution and 256 (19.6%) had plasmacytomas (Ps) (paraskeletal –PPs- 17.6%, extramedullary –EMPs-1.9%). Patients with Ps had lower serum
Externí odkaz:
https://doaj.org/article/5e019032e0d549be9f149145a0b9acc3
Autor:
Anthony M. Battram, Aina Oliver-Caldés, Maria Suárez-Lledó, Miquel Lozano, Miquel Bosch i Crespo, Núria Martínez-Cibrián, Joan Cid, David F. Moreno, Luis Gerardo Rodríguez-Lobato, Alvaro Urbano-Ispizua, Carlos Fernández de Larrea
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 26, Iss , Pp 207-223 (2022)
Autologous cell immunotherapy using B cell maturation antigen (BCMA)-targeted chimeric antigen receptor (CAR)-T cells is an effective novel treatment for multiple myeloma (MM). This therapy has only been used for relapsed and refractory patients, at
Externí odkaz:
https://doaj.org/article/85ce7bb7085742eaa47debfe86d2dbc9
Autor:
Aina Oliver-Caldes, Juan Carlos Soler-Perromat, Ester Lozano, David Moreno, Alex Bataller, Pablo Mozas, Marta Garrote, Xavier Setoain, Juan Ignacio Aróstegui, Jordi Yagüe, Natalia Tovar, Raquel Jiménez, Luis Gerardo Rodríguez-Lobato, M. Teresa Cibeira, Laura Rosiñol, Joan Bladé, Manel Juan, Carlos Fernández de Larrea
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionMultiple myeloma (MM) is considered an incurable hematological neoplasm. For transplant-eligible patients, initial treatment includes an induction phase followed by an autologous stem cell transplantation (ASCT). Despite the introduction
Externí odkaz:
https://doaj.org/article/e5fabab14d0d45a2ac2c95f79c8116fd
Autor:
Ignacio Isola, Fara Brasó-Maristany, David F. Moreno, Mari-Pau Mena, Aina Oliver-Calders, Laia Paré, Luis Gerardo Rodríguez-Lobato, Beatriz Martin-Antonio, María Teresa Cibeira, Joan Bladé, Laura Rosiñol, Aleix Prat, Ester Lozano, Carlos Fernández de Larrea
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundWe previously reported algorithms based on clinical parameters and plasma cell characteristics to identify patients with smoldering multiple myeloma (SMM) with higher risk of progressing who could benefit from early treatment. In this work,
Externí odkaz:
https://doaj.org/article/b9061fb81fbb4274961401c2b3964701
Autor:
Daniel Camprubí, Anna Gaya, Maria Angeles Marcos, Helena Martí-Soler, Alex Soriano, Maria del Mar Mosquera, Aina Oliver, Marta Santos, Jose Muñoz, Carol García-Vidal
Publikováno v:
International Journal of Infectious Diseases, Vol 104, Iss , Pp 379-381 (2021)
Microbiological response of SARS-CoV-2 to remdesivir in immunocompromised patients has not been evaluated. We present the case of a severely immunocompromised patient with persistent replication of SARS-CoV-2, who required different courses of remdes
Externí odkaz:
https://doaj.org/article/2e2dc8aef7574611b3098694a770fd7b
Autor:
David F. Moreno, Mónica López‐Guerra, Sara Paz, Aina Oliver‐Caldés, Mari‐Pau Mena, Juan G. Correa, Anthony M. Battram, Miguel Osuna, Alfredo Rivas‐Delgado, Luis Gerardo Rodríguez‐Lobato, Oriol Cardús, Natalia Tovar, María Teresa Cibeira, Raquel Jiménez‐Segura, Joan Bladé, Laura Rosiñol, Dolors Colomer, Carlos Fernández de Larrea
Publikováno v:
British Journal of Haematology. 200:187-196
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d38a3f4ddaa804771be4d1e3a6454c2e
https://doi.org/10.1111/bjh.18502
https://doi.org/10.1111/bjh.18502